Established in 2021, NewCan Biotech Limited is a technology-based enterprise focused on the research and development of sugars, nucleosides, nucleotides, and phosphorylated monomers. We are committed to providing high-quality raw materials and products for the pharmaceutical, biotechnology, and food industries through innovative research and technological development. As industry leaders, we continuously strive for excellence, aiming to drive industry development and innovation. Our product features include high purity, efficiency, and customizability to meet diverse customer needs and applications. We have an experienced, passionate, and creative research and development team that continuously explores cutting-edge technologies to ensure our products remain at the forefront of the industry. We adhere to strict quality management systems to ensure all products meet international standards and customer requirements. Additionally, we prioritize environmental protection and sustainable development, working towards promoting green production and recycling. We look forward to collaborating with global partners to jointly explore markets and achieve mutual benefits. In the future, we will continue to uphold an innovative spirit, enhance technological capabilities, and provide customers with higher quality products and services, becoming leaders and innovators in the industry.
In order to provide better products and related services to customers, NewCan Biotech Limited has upgraded the sales team's system. Based on the updated ERP system, all the information of customers and product will be recorded more completely, so that the historical data can be better provided for your reference in the future cooperation.
At the same time, relying on this ERP system, we can also better update the product catalog and improve the quotation efficiency in future work.
The 2023 Nobel Prize in Physiology or Medicine is jointly awarded to Katalin Karikó and Drew Weissman "for their discoveries in nucleoside base modifications leading to the development of effective COVID-19 mRNA vaccines."
They have contributed to the unprecedented speed of vaccine development. The two Nobel laureates' discoveries were crucial in developing an effective mRNA vaccine during the COVID-19 pandemic that began in early 2020. Through their groundbreaking discoveries that fundamentally changed our understanding of how messenger RNA interacts with the immune system, the laureates contributed to the unprecedented speed of vaccine development against one of the greatest threats to human health in modern times.
https://www.nobelprize.org/prizes/medicine/2023/press-release/
At the end of 2023, NewCan Biotech Limited relocated its company address.
Putting people first will always be an important part of the corporate culture of Hangzhou Newcan. While pursuing corporate benefits, we also do our best to provide employees with a comfortable, safe and good working environment. The company's new address is located in the Digital Culture Development Center of Hangzhou, adjacent to the city's key technology development enterprises. It will do bring a better experience to the company and employees, both in terms of life convenience and environment. We also hope to achieve further development of the company in the new environment. All customers are welcome to visit us.
